跳至主要内容
临床试验/NCT05374642
NCT05374642已完成不适用

Randomized Controlled Trial of Computerized Cognitive Training in Patients With Atrial Fibrillation With Cognitive Impairment But Without Dementia

Beijing Anzhen Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2022年9月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200
试验地点
1
主要终点
global cognitive change in 12 weeks

研究概览

简要总结

The objective of the study is to evaluate the effectiveness of cognitive training in people with atrial fibrillation and cognitive decline over 12-week cognitive training. Moreover, the investigators will explore whether the training effect can be maintained.

详细描述

Introduction

Cognitive impairment is a clinical condition characterized of a reduction in memory and/or other cognitive processes that are insufficiently severe to be diagnosed as dementia.The prevalence of dementia among people over 65 years old in China is 5.14% , while the prevalence of mild cognitive impairment is 20.8%. The risk of cognitive impairment and dementia in patients with atrial fibrillation is significantly higher than that those in the same age group, even after adjusted stroke and other common risk factors such as hypertension and diabetes. At present, the effectiveness of cognitive training in patients with atrial fibrillation complicated with cognitive impairment is not clear.

Objectives: The objective of the study is to evaluate whether cognitive training could lead cognitive improvement in patients with cognitive impairment and atrial fibrillation.

Patients and Methods: The proposed study is a double blinded, randomized and controlled trial that will include 200 patients with cognitive impairment and atrial fibrillation. The groups will be randomized to either intervention or active-control group. Both groups will receive computerized cognitive training performed for 30 minutes x 5 times/week over 12 weeks. A neuropsychological assessment will be administered at baseline and week 12 and 24 after the intervention. The structural and functional MRI will be performed at baseline and week 12 after intervention for a sub-study on the effect of cognitive training on brain structure and function.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Older than 18 years;
  • Completion of 6 or more years of education;
  • Atrial fibrillation confirmed by ECG ;
  • Complain of memory decline within 1 year;
  • The score of any cognitive domain in the processing speed, episodic memory, working memory, and visual-spatial tested by the Basic Cognitive Ability Assessment (BCAT) is 1SD less than the average of the normal population;
  • Agree to receive cognitive function testing and randomization, be able to receive follow-up as required

排除标准

  • Unable to complete the test due to vision, hearing and other problems;
  • Dementia or MMSE Scale ≤ 20;
  • Alcohol abuse or taking drugs that affect cognitive function (antihistamines, antipsychotics);
  • Cannot master the method of cognitive training tool after 2 times, 1 hour each time training instruction;
  • Planned atrial fibrillation ablation within 3 months or received ablation in the last 3 months;
  • CHA2DS2-VASc score ≥ 2 (for female ≥ 3), but refuses anticoagulation or has anticoagulation contraindications;
  • General anaesthesia in the last 3 months;
  • A history of stroke and head injury in the last 6 months;
  • Past history of Parkinson's disease, schizophrenia, and epilepsy;
  • Previous neurosurgery or a history of head tumor;
  • Contraindications for MRI examination: such as metal implantation, claustrophobia, etc.;
  • No family members to assist the patients to do the training course

结局指标

主要结局

global cognitive change in 12 weeks

时间窗: 12 weeks after randomization

The percentage of patients whose global cognitive function measured at 12 weeks after intervention improves 0.67 SD compared to that measured at baseline by basic cognitive ability test (BCAT)

次要结局

  • global cognitive change in 24 weeks(24 weeks after randomization)
  • domain cognitive change(12 weeks, 24 weeks after randomization)
  • quality of life scores(12 weeks, 24 weeks after randomization)
  • cognitive score change(12 weeks, 24 weeks after randomization)
  • self-efficacy scores(12 weeks, 24 weeks after randomization)
  • anxiety and depression scores(12 weeks, 24 weeks after randomization)

研究者

发起方
Beijing Anzhen Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chang sheng Ma

Prof.

Beijing Anzhen Hospital

研究点 (1)

Loading locations...

相似试验